A study of dental implants in medically treated hypothyroid patients

Clinical implant dentistry and related research

Volumn 4, Issue 4, 2002, Pages 220-231

  Attard, Nikolai J ^a   Zarb, George A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

THYROXINE;

ADULT; ARTICLE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; DENTAL CARE; DENTAL SURGERY; DRUG CONTRAINDICATION; FEMALE; HUMAN; HYPOTHYROIDISM; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOLYSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SURVIVAL; TOOTH IMPLANTATION;

ADULT; ALVEOLAR BONE LOSS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DENTAL CARE FOR CHRONICALLY ILL; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; DENTAL RESTORATION FAILURE; FEMALE; HUMANS; HYPOTHYROIDISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THYROXINE;

EID: 0038519759     PISSN: 15230899     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1708-8208.2002.tb00174.x     Document Type: Article

References (66)

1. 1 Adell R, Lekholm U, Rockler B, Brånemark PI. A 15‐year study of osseointegrated implants in the treatment of the edentulous jaws. Int J Oral Surg 1981 ; 10: 387–416.
2. 2 Lindquist LW, Carlsson GE, Jemt T. A prospective 15‐year follow‐up study of mandibular fixed prostheses supported by osseointegrated implants. Clin Oral Implants Res 1996 ; 7: 329–336.
3. 3 Zarb GA, Schmitt A. The edentulous predicament. I: A prospective study of the effectiveness of implant supported fixed prostheses. J Am Dent Assoc 1996 ; 127: 59–65.
4. 4 Zarb G, Schmitt A. The edentulous predicament. II: The longitudinal effectiveness of implant supported overdentures. J Am Dent Assoc 1996 ; 127: 66–72.
5. 5 Henry PJ, Bower RC, Wall CD. Rehabilitation of the edentulous mandible with osseointegrated dental implants: 10‐year follow‐up. Aust Dent J 1995 ; 40: 1–9.
6. 6 Zarb GA, Schmitt A. The longitudinal clinical effectiveness of osseointegrated dental implants in posterior partially edentulous patients. Int J Prosthodont 1993 ; 6: 186–189.
7. 7 Zarb GA, Schmitt A. The longitudinal clinical effectiveness of osseointegrated dental implants in anterior partially edentulous patients. Int J Prosthodont 1993 ; 6: 180–186.
8. 8 Wyatt CC. Treatment outcomes of patients with implant supported fixed partial prostheses. Thesis, University of Toronto, Toronto, Canada, 1996.
9. 9 Lekholm U, van Steenberghe D, Herman I, et al, Osseointegrated implants in the treatment of posterior partially edentulous jaws: a 5‐year multi‐center study. Int J Oral Maxillofac Implants 1994 ; 9: 627–635.
10. 10 Sennerby L, Roos J. Surgical determinants of clinical success of osseointegrated oral implants: a review of the literature. Int J Prosthodont 1998 ; 11: 408–420.
11. 11 Esposito M. On biological failures of osseointegrated oral implants. Thesis, University of Göteborg, Sweden, 1999.
12. 12 Burch WM, Lebovitz HE. Triiodothyronine stimulates maturation of porcine growth‐plate cartilage in vitro. J Clin Invest 1982 ; 703: 496–504.
13. 13 Burch WM, Lebovitz HE. Triiodothyronine stimuiation of in vitro growth and maturation of embryonic chick cartilage. Endocrinology 1982 ; 1112: 462–468.
14. 14 Burch WM, van Wyk JJ. Triiodothyronine stimulates cartilage growth and maturation by different mechanisms. Am J Physiol 1987 ; 252 (2 Pt 1): E176–182.
15. 15 Lewinson D, Harel Z, Shenzer P, Silbermann M, Hochberg Z. Effect of thyroid hormone and growth hormone on recovery from hypothyroidism of epiphyseal growth plate cartilage and its adjacent bone. Endocrinology 1989 ; 124: 937–945.
16. 16 Urabe K, Hotokebuchi T, Oles KJ, et al. Inhibition of endochondral ossification during fracture repair in experimental hypothyroid rats. J Orthop Res 1999 ; 17: 920–925.
17. 17 Herndon DN, Wilmore DW, Mason AD, Curreri PW. Increased rates of wound healing in burned guinea pigs treated with L‐thyroxine. Surg Forum 1979 ; 30: 95–97.
18. 18 Kivirikko KI, Laitinen O, Aer J, Halme J. Metabolism of collagen in experimental hyperthyroidism and hypothyroidism in the rat. Endocrinology 1967 ; 80: 1051–1061.
19. 19 Lennox J, Johnston ID. The effect of thyroid status on nitrogen balance and the rate of wound healing after injury in rats. Br J Surg 1973 ; 60: 309.
20. 20 Erdogan M, Ilhan YS, Akkus MA, et al. Effects of L‐thyroxine and zinc therapy on wound healing in hypothyroid rats. Acta Chir Belg 1999 ; 99 (2): 72–77.
21. 21 Eriksen EF. Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normal and in metabolic bone disease. Endocrinol Rev 1986 ; 7: 379–408.
22. 22 Mosekilde L, Eriksen EF, Charles P. Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 1990 ; 19 (1): 35–63.
23. 23 Krolner B, Jorgensen JV, Nielsen SP. Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone(s) and antithyroid treatment. Clin Endocrinol (Oxf) 1983 ; 18: 439–446.
24. 24 Kung A, Pun KK. Bone mineral density in premenopausal women receiving long‐term physiological doses of levothyroxine. JAMA 1991 ; 265: 2688–2691.
25. 25 Garton M, Reid I, Loveridge N, et al. Bone mineral density and metabolism in premenopausal women taking l‐thyroxine replacement therapy. Clin Endocrinol (Oxf) 1994 ; 41: 747–755.
26. 26 Campos‐Pastor MM, Munoz‐Torres M, Escobar‐Jimenez F, Ruiz de Almodovar M, Jodar Gimeno E. Bone mass in females with different thyroid disorders: influence of menopausal status. Bone Miner 1993 ; 21 (1): 1–8.
27. 27 Hadji P, Hars O, Sturm G, Bauer T, Emons G, Schulz KD. The effect of long‐term, non‐suppressive levothyroxine treatment on quantitative ultrasonometry of bone in women. Eur J Endocrinol 2000 ; 142: 445–450.
28. 28 Duncan WE, Chang A, Solomon B, Wartofsky L. Influence of clinical characteristics and parameters associated with thyroid hormone therapy on the bone mineral density of women treated with thyroid hormone. Thyroid 1994 ; 4: 183–190.
29. 29 Franklyn J, Betteridge J, Holder R, Daykin J, Lilley J, Sheppard M. Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis. Clin Endocrinol 1994 ; 41: 425–432.
30. 30 Ross DS. Bone density is not reduced during the short‐term administration of levothyroxine to postmenopausal women with subclinical hypothyroidism: a randomized, prospective study. Am J Med 1993 ; 95: 385–388.
31. 31 Ross D, Ardisson L, Meskell M. Measurement of thyrotropin in clinical and subclinical hyperthyroidism using a new chemiluminescent assay. J Clin Endocrinol Metab 1989 ; 69: 684–688.
32. 32 Leese G, Jung R, Guthrie C, Waugh N, Browning M. Morbidity of patients on L‐thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH. Clin Endocrinol 1992 ; 37: 500–503.
33. 33 Foldes J, Tarjan G, Szathmari M, Varga F, Krasznai I, Horvath C. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis Clin Endocrinol (Oxf) 1993 ; 39: 521–527.
34. 34 Stall GM, Harris S, Sokoll LJ, Dawson‐Hughes B. Accelerated bone loss in hypothyroid patients over‐treated with l ‐ thyroxine. Ann Intern Med 1990 ; 113: 265–269.
35. 35 Pines A, Dotan I, Tabori U, et al. l ‐thyroxine prevents the bone‐conserving effect of HRT in postmenopausal women with subclinical hypothyroidism. Gynecol Endocrinol 1999 ; 13: 196–201.
36. 36 Pioli G, Pedrazzoni M, Palummeri E, et al. Longitudinal study of bone loss after thyroidectomy and suppressive thyroxine therapy in premenopausal women. Acta Endocrinol (Copenh) 1992 ; 126: 238–242.
37. 37 McDermott MT, Perloff JJ, Kidd GS. A longitudinal assessment of bone loss in women with levothyroxine‐suppressed benign thyroid disease and thyroid cancer. Calcif Tissue Int 1995 ; 56: 521–525.
38. 38 Guo CY, Weetman AP, Eastell R. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine. Clin Endocrinol (Oxf) 1997 ; 46: 301–307.
39. 39 De Rosa G, Testa A, Giacomini D, Carrozza C, Astazi P, Caradonna P. Prospective study of bone loss in pre‐ and post‐menopausal women on l ‐thyroxine therapy for nontoxic goiter. Clin Endocrinol (Oxf) 1997 ; 47: 529–535.
40. 40 Grant DJ, McMurdo ME, Mole PA, Paterson CR, Davies RR. Suppressed TSH levels secondary to thyroxine replacement therapy are not associated with osteoporosis. Clin Endocrinol (Oxf) 1993 ; 39: 529–533.
41. 41 Muller CG, Bayley TA, Harrison JE, Tsang R. Possible limited bone loss with suppressive thyroxine therapy is unlikely to have clinical relevance. Thyroid 1995 ; 5: 81–87.
42. 42 Franklyn JA, Betteridge J, Daykin J, et al. Long‐term thyroxine treatment and bone mineral density. Lancet 1992 ; 340 (8810): 9–13.
43. 43 Marcocci C, Golia F, Bruno‐Bossio G, Vignali E, Pinchera A. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. J Clin Endocrinol Metab 1994 ; 78: 818–823.
44. 44 Giannini S, Nobile M, Sartori L, et al. Bone density and mineral metabolism in thyroidectomized patients treated with long‐term l‐thyroxine. Clin Sci (Colch) 1994 ; 87: 593–597.
45. 45 Hirai T, Ishijima T, Hashikawa Y, Yajima T. Osteoporosis and reduction of residual ridge in edentulous patients. J Prosthet Dent 1993 ; 69: 49–56.
46. 46 Kribbs PJ, Chesnut CH, Ott SM, Kilcoyne RF. Relationships between mandibular and skeletal bone in an osteoporotic population. J Prosthet Dent 1989 ; 62: 703–707.
47. 47 Kribbs PJ. Comparison of mandibular bone in normal and osteoporotic women. J Prosthet Dent 1990 ; 63: 218–222.
48. 48 Kribbs PJ, Chesnut CH, Ott SM, Kilcoyne RF. Relationships between mandibular and skeletal bone in a population of normal women. J Prosthet Dent 1990 ; 63: 86–89.
49. 49 Ward VJ, Stephens AP, Harrison A, Lurie D. The relationship between the metacarpal index and the rate of mandibular ridge resorption. J Oral Rehabil 1977 ; 4 (1): 83–89.
50. 50 Mohajery M, Brooks SL. Oral radiographs in the detection of early signs of osteoporosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1992 ; 73: 112–117.
51. 51 Ortman LF, Hausmann E, Dunford RG. Skeletal osteopenia and residual ridge resorption. J Prosthet Dent 1989 ; 61: 321–325.
52. 52 von Wowern N, Kollerup G. Symptomatic osteoporosis: a risk factor for residual ridge reduction of the jaws. J Prosthet Dent 1992 ; 67: 656–660.
53. 53 Klemetti E, Vainio P. Effect of bone mineral density in skeleton and mandible on extraction of teeth and clinical alveolar height. J Prosthet Dent 1993 ; 70: 21–25.
54. 54 Klemetti E, Vainio P, Lassila V, Alhava E. Cortical bone mineral density in the mandible and osteoporosis status in postmenopausal women. Scand J Dent Res 1993 ; 101: 219–223.
55. 55 Wyatt CL, Zarb GA. Treatment outcomes with implant supported fixed partial prosthesis. Int J Oral Maxillofac Implants 1998 ; 13: 204–211.
56. 56 Lekholm U, Zarb GA. Patient selection and preparation. In: Branemark PI, Zarb GA, Albrektsson T, eds. Tissue integrated prostheses: osseointegration in clinical dentistry. Chicago: Quintessence, 1985: 199–209.
57. 57 Zarb G, Albreksston T. Consensus report: towards optimized treatment outcomes for dental implants. Int J Prosthodont 1998 ; 11: 389.
58. 58 Cox JF, Pharaoh M. An alternative holder for radiographic evaluation of tissue integrated prostheses. J Prosthet Dent 1986 ; 56: 338–341.
59. 59 Avivi‐Arber L. Prosthodontic replacement of the missing single tooth with implant‐supported prostheses admodum Bränemark. Thesis, University of Toronto, Toronto, Canada, 1994.
60. 60 Rasband W. NIH Image Software 1.54. Bethesda (MD): National Institutes of Health (US); 1986 Report No.: PB93‐504868.
61. 61 Sawin C, Geller A, Hershman J, Castelli W, Bacharach P. The aging thyroid. The use of thyroid hormone in older persons. JAMA 1989 ; 261: 2653–2655.
62. 62 Harvey RD, McHardy KG, Reid IW, et al. Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium crosslinks as specific urinary markers. J Clin Endocrinol Metab 1991 ; 72: 1189–1194.
63. 63 Bergendal T, Engquist B. Implant‐supported overdentures: a longitudinal prospective study. Int J Oral Maxillofac Implants 1998 ; 13: 253–262.
64. 64 Lekholm U, Gunne J, Henry P, et al. Survival of the Brånemark implant in partially edentulous jaws: a 10‐year prospective multicenter study. Int J Oral Maxillofac Implants 1999 ; 14: 639–645.
65. 65 Gunne J, Astrand P, Lindh T, Borg K, Olsson M. Toothimplant and implant supported fixed partial dentures: a 10‐year report. Int J Prosthodont 1999 ; 12: 216–221.
66. 66 Jemt T, Lekholm U. Oral implant treatment in posterior partially edentulous jaws: a 5‐year follow‐up report. Int J Oral Maxillofac Implants 1993 ; 8: 635–640.